MYCDCGP - Clinical Practice Guidelines - Management of Drug Resistance of Tuberculosis
Author | : Bahagian Kawalan Penyakit, Kementerian Kesihatan Malaysia |
Publisher | : BKPKKM |
Total Pages | : 118 |
Release | : |
Genre | : |
ISBN | : |
Download Mycdcgp Clinical Practice Guidelines Management Of Drug Resistance Of Tuberculosis full books in PDF, epub, and Kindle. Read online free Mycdcgp Clinical Practice Guidelines Management Of Drug Resistance Of Tuberculosis ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author | : Bahagian Kawalan Penyakit, Kementerian Kesihatan Malaysia |
Publisher | : BKPKKM |
Total Pages | : 118 |
Release | : |
Genre | : |
ISBN | : |
Author | : Bahagian Kawalan Penyakit, Kementerian Kesihatan Malaysia |
Publisher | : BKPKKM |
Total Pages | : 83 |
Release | : |
Genre | : |
ISBN | : |
Author | : Bahagian Kawalan Penyakit, Kementerian Kesihatan Malaysia |
Publisher | : BKPKKM |
Total Pages | : 126 |
Release | : |
Genre | : Medical |
ISBN | : |
Author | : World Health Organization |
Publisher | : |
Total Pages | : 99 |
Release | : 2019 |
Genre | : |
ISBN | : |
Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult to treat than drug-susceptible ones, and threaten global progress towards the targets set by the End TB Strategy of the World Health Organization (WHO). There is thus a critical need for evidence-based policy recommendations on the treatment and care of patients with DR-TB, based on the most recent and comprehensive evidence available. In this regard, the WHO consolidated guidelines on drug-resistant tuberculosis treatment fulfil the mandate of WHO to inform health professionals in Member States on how to improve treatment and care for patients with DR-TB. Between 2011 and 2018, WHO has developed and issued evidence-based policy recommendations on the treatment and care of patients with DR-TB. These policy recommendations have been presented in several WHO documents and their associated annexes, including the WHO treatment guidelines for multidrug- and rifampicin-resistant tuberculosis, 2018 update, issued by WHO in December 2018. The policy recommendations in each of these guidelines have been developed by WHO-convened Guideline Development Groups (GDGs), using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach to summarize the evidence, and formulate policy recommendations and accompanying remarks. The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, including longer and shorter regimens, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), use of surgery for patients receiving MDR-TB treatment, and optimal models of patient support and care.
Author | : World Health Organization |
Publisher | : WHO |
Total Pages | : 174 |
Release | : 2006-01-01 |
Genre | : Medical |
ISBN | : 9789241546959 |
The emergence of resistance to drugs used to treat tuberculosis (TB), particularly multidrug-resistant TB (MDR-TB), has become a significant public health problem in some countries, whilst in many others the extent of the problem is unknown. These guidelines set out updated recommendations for TB control programmes in low and middle income countries based on the best current knowledge in the management of MDR-TB. The guidelines are based on a flexible framework approach which can be adapted to suit diverse local circumstances. The DOTS strategy remains the most effective tool to prevent the onset and dissemination of drug resistance, and these guidelines focus on care for MDR-TB patients, in the hope and expectation that, in future, the occurrence of massive numbers of cases can be prevented through sound TB control practices.
Author | : World Health Organization |
Publisher | : World Health Organization |
Total Pages | : 0 |
Release | : 2018-11-07 |
Genre | : Medical |
ISBN | : 9789241550529 |
Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult to treat than drug-susceptible ones, and threaten global progress towards the targets set by the End TB Strategy of the World Health Organization (WHO). There is thus a critical need for evidence-based policy recommendations on the treatment and care of patients with DR-TB, based on the most recent and comprehensive evidence available. In this regard, the WHO consolidated guidelines on drug-resistant tuberculosis treatment fulfil the mandate of WHO to inform health professionals in Member States on how to improve treatment and care for patients with DR-TB. Between 2011 and 2018, WHO has developed and issued evidence-based policy recommendations on the treatment and care of patients with DR-TB. These policy recommendations have been presented in several WHO documents and their associated annexes, including the WHO treatment guidelines for multidrug- and rifampicin-resistant tuberculosis, 2018 update, issued by WHO in December 2018. The policy recommendations in each of these guidelines have been developed by WHO-convened Guideline Development Groups (GDGs), using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach to summarize the evidence, and formulate policy recommendations and accompanying remarks. The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, including longer and shorter regimens, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), use of surgery for patients receiving MDR-TB treatment, and optimal models of patient support and care.
Author | : Bahagian Kawalan Penyakit, Kementerian Kesihatan Malaysia |
Publisher | : BKPKKM |
Total Pages | : 100 |
Release | : |
Genre | : |
ISBN | : |
Author | : Tami Ross |
Publisher | : American Dietetic Associati |
Total Pages | : 314 |
Release | : 2005 |
Genre | : Health & Fitness |
ISBN | : 0880913339 |
Medical nutrition therapy plays an integral role in the management in diabetes. This comprehensive guide is an evidence-based review of MNT and the Nutrition Care Process and a practical reference of diabetes management tools and nutrition education. Covering practice guidelines, outcomes evaluation, nutrition assessments, goal-setting, behavior change and interventions, this guide is a must-have resource for health-care professionals serving the diabetes community.